Jupiter Investment Management’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-21,024
Closed -$3.74M 528
2019
Q3
$3.74M Sell
21,024
-71,389
-77% -$15.4M 0.05% 263
2019
Q2
$24.1M Sell
92,413
-417,310
-82% -$111M 0.25% 108
2019
Q1
$146M Sell
509,723
-132,560
-21% -$44.1M 1.34% 28
2018
Q4
$209M Buy
642,283
+3,427
+0.5% +$1.19M 1.85% 11
2018
Q3
$287M Buy
638,856
+582,318
+1,030% +$230M 1.96% 7
2018
Q2
$23.1M Buy
+56,538
New +$20.5M 0.16% 121
2016
Q2
Sell
-145,127
Closed -$13.8M 537
2016
Q1
$13.8M Sell
145,127
-38,056
-21% -$3.21M 0.28% 102
2015
Q4
$16.5M Buy
183,183
+86,711
+90% +$7.36M 0.44% 77
2015
Q3
$8.95M Buy
96,472
+85,857
+809% +$7.56M 0.25% 101
2015
Q2
$697K Buy
+10,615
New +$705K 0.02% 205

Other funds holding ABMD

Jupiter Investment Management's ABMD Position: Q4 2019 in Review

Jupiter Investment Management sold out of Abiomed Inc (ABMD) in Q4 2019, closing a stake of 21,024 shares — an estimated $3.74M sold.

Jupiter Investment Management first reported a position in ABMD in Q2 2015 and held it in 10 quarters. The position peaked at $287M in Q3 2018. 465 funds tracked by Wall St. Rank hold ABMD as of Q4 2019.

  • Jupiter Investment Management reported no remaining Abiomed Inc position as of Q4 2019 after selling out during the quarter.
  • Jupiter Investment Management sold 21,024 Abiomed Inc shares in Q4 2019, an estimated $3.74M.
  • Jupiter Investment Management first reported a position in Abiomed Inc in Q2 2015 and held it in 10 quarters.
  • Jupiter Investment Management's Abiomed Inc position peaked at $287M in Q3 2018.
  • 465 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2019.

Based on Jupiter Investment Management's 13F filing for Q4 2019, filed 3 Feb 2020.